Qurient Co., Ltd.

Qurient Co., Ltd. is a biotechnology company primarily engaged in the development of innovative therapeutics targeting cancer and inflammatory diseases. The company focuses on advancing its proprietary pipeline of small molecule drugs through rigorous research and development. Qurient Co., Ltd. aims to address unmet medical needs by leveraging its expertise in immuno-oncology and NCE (new chemical entity) drug discovery platforms. The company's endeavors encompass the stages from preclinical studies through clinical trials, striving for breakthroughs that enhance patient care and outcomes. Operating within the dynamic biopharmaceutical sector, Qurient plays a critical role in the advancement of healthcare technology and therapeutics. Headquartered in South Korea, the company collaborates with academic institutions and industry partners globally to achieve its objectives. Qurient Co., Ltd. stands out in the healthcare market by contributing to the innovation of treatment options, thereby holding significance in reshaping therapeutic landscapes.